Skip to content
Stop using now Drug recall · FDA · Published June 4, 2013

Recall: Cleocin Phosphate Vials with Glass Particulates

Pharmacia & Upjohn recalls specific lots of Cleocin Phosphate Injection due to glass particulate matter. Check lot numbers and expiration dates.

🇺🇸 FDA recall #D-609-2013DrugCleocin ›
Take action

Contact the company

Recalling firmPharmacia & Upjohn LLC7000 Portage Rd · Kalamazoo, MI 49001-0102
✎ GovInfoNow plain-language explainer

Pharmacia & Upjohn LLC is recalling a small number of Cleocin Phosphate (clindamycin Injection) ADD-Vantage Vials because they may contain very small reflective flakes consistent with delamination of the glass vial. This defect poses a risk of particulate matter entering the patient's bloodstream during intravenous use. The recall affects specific lots distributed nationwide. Read more at govinfonow.com/recall/47465-pharmacia-upjohn-llc-recalls-cleocin-phosphate-clindamycin-injection-usp-a.

Source Summary by GovInfoNow · govinfonow.com/recall/47465-pharmacia-upjohn-llc-recalls-cleocin-phosphate-clindamycin-injection-usp-a · Updated October 13, 2026 · FDA enforcement record: FDA #D-609-2013

Cite this page

“Recall: Cleocin Phosphate Vials with Glass Particulates.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47465-pharmacia-upjohn-llc-recalls-cleocin-phosphate-clindamycin-injection-usp-a. Based on FDA recall #D-609-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-609-2013%22&limit=1).

The FDA announced on June 4, 2013, that Pharmacia & Upjohn LLC is recalling Cleocin Phosphate (clindamycin Injection), USP vials due to the presence of particulate matter. The hazard involves very small reflective flakes consistent with glass vial delamination.

How to tell if you have it

  • Brand: Cleocin
  • Product: Cleocin Phosphate Injection
  • NDC a) 0009-3124-03 and b) 0009-3447-03
  • Lots a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14 and b) G34910, Exp 06/14; G36879, G41005, Exp 07/14; G53478, Exp 09/14; G63444, Exp 10/14; G76317, Exp 11/14

The hazard

The recall addresses the presence of particulate matter in a small number of vials. The firm identified very small reflective flakes consistent with delamination of the glass vial.

Context

GovInfoNow's records show other recent recalls of similar products include Heritage Pharma Recalls Clindamycin Oral Solution Due to Foreign Particles (2026-07-30) and American Regent Papaverine HCl Injection Recall: Particulate Matter Hazard (2026-07-24). American Regent Epinephrine Injection Recall: Particulate Matter Risk occurred on 2026-08-11.

How to tell if you have this one

Check for Cleocin Phosphate (clindamycin Injection), USP, 600 mg/4mL or 900 mg/6mL ADD-Vantage Vials. Look for NDC numbers 0009-3124-03 or 0009-3447-03. Affected lots include G34908, G53479, G63442, G58347, G80133, G34910, G36879, G41005, G53478, G63444, and G76317.

  • Brand
    Cleocin
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify Affected Lots

    Verify if your inventory includes Cleocin Phosphate Injection with NDCs 0009-3124-03 or 0009-3447-03 and the specific lot numbers listed in the recall.

  2. Stop Using Affected Vials

    Do not use any vials from the recalled lots due to the risk of glass particulate contamination.

  3. Contact Manufacturer for Remedy

    The recall record does not specify a remedy or return process; contact Pharmacia & Upjohn LLC for further instructions on how to handle these products.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Jun 4, 201312. FDA classified it Class II: Jun 20, 201323. Published in FDA’s Enforcement Report: Jun 26, 201334. FDA terminated the recall: Apr 17, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-609-2013 (June 4, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-609-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA